Cite
Fukuda Y, Wang Y, Lian S, et al. Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. JCI Insight. 2017;2(15)doi: 10.1172/jci.insight.92409.
Fukuda, Y., Wang, Y., Lian, S., Lynch, J., Nagai, S., Fanshawe, B., Kandilci, A., Janke, L. J., Neale, G., Fan, Y., Sorrentino, B. P., Roussel, M. F., Grosveld, G., & Schuetz, J. D. (2017). Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. JCI insight, 2(15), . https://doi.org/10.1172/jci.insight.92409
Fukuda, Yu, et al. "Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis." JCI insight vol. 2,15 (2017). doi: https://doi.org/10.1172/jci.insight.92409
Fukuda Y, Wang Y, Lian S, Lynch J, Nagai S, Fanshawe B, Kandilci A, Janke LJ, Neale G, Fan Y, Sorrentino BP, Roussel MF, Grosveld G, Schuetz JD. Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. JCI Insight. 2017 Aug 03;2(15). doi: 10.1172/jci.insight.92409. eCollection 2017 Aug 03. PMID: 28768907; PMCID: PMC5543914.
Copy
Download .nbib